Article Per Year (5 Year)
p-Index From 2020 - 2025
0
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran
-, Effendi
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Tatalaksana Fibrilasi Atrium -, Effendi
Cermin Dunia Kedokteran Vol 44, No 2 (2017): Neurologi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (220.048 KB) | DOI: 10.55175/cdk.v44i2.816

Abstract

Fibrilasi atrium merupakan jenis aritmia dengan insiden yang terus meningkat. Penderita fibrilasi atrium umumnya memiliki kelainan struktur jantung atau penyakit sistemik.Terapi umum adalah anti-trombotik untuk pencegahan stroke, pengendalian laju jantung dan pengendalian ritme jantung.Atrial fibrillation is an arrhythmia with increasing incidence. Atrial fibrillation is often associated with structural heart disease or other systemic disease. Treatment is based on anti-thrombotic agent for stroke prevention, rate control and rhythm control.
Efektivitas dan Peran Montelukast (LTRA) pada Pasien Asma Kronis -, Adhitya; -, Effendi
Cermin Dunia Kedokteran Vol 44, No 12 (2017): Neurologi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (224.357 KB) | DOI: 10.55175/cdk.v44i12.695

Abstract

Asma merupakan penyakit saluran nafas kronik dengan gejala obstruksi akibat respon inflamasi. Pedoman tatalaksana asma saat ini menyatakan kortikosteroid sebagai terapi lini pertama untuk mengontrol penyakit. Namun, kortikosteroid memiliki banyak efek samping. Berdasarkan patofisiologi asma yang beragam, beberapa obat lain dapat digunakan untuk mengontrol asma, salah satunya adalah montelukast yang termasuk golongan Leukotriene Receptor Antagonist (LTRA).Asthma is a chronic respiratory disease with airway obstruction as the main symptom, caused by inflammation responses. Asthma management guidelines state that corticosteroid is the mainstay therapy for asthma. But, corticosteroid has many side effects. Based on the patophysiology of asthma, other drugs can be used to control asthma, one of them is montelukast which belongs to leukotriene receptor antagonist (LTRA) group.
Co-Authors -, Adhitya